Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Immunity from smallpox vaccine persists for decades: a longitudinal study.

Taub DD, Ershler WB, Janowski M, Artz A, Key ML, McKelvey J, Muller D, Moss B, Ferrucci L, Duffey PL, Longo DL.

Am J Med. 2008 Dec;121(12):1058-64. doi: 10.1016/j.amjmed.2008.08.019.

2.

Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax.

Midgley CM, Putz MM, Weber JN, Smith GL.

J Gen Virol. 2008 Dec;89(Pt 12):2992-7. doi: 10.1099/vir.0.2008/004440-0.

3.

Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.

Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.

J Virol. 2008 Jul;82(14):6829-37. doi: 10.1128/JVI.00353-08. Epub 2008 Apr 30.

4.

A rapid, high-throughput vaccinia virus neutralization assay for testing smallpox vaccine efficacy based on detection of green fluorescent protein.

Johnson MC, Damon IK, Karem KL.

J Virol Methods. 2008 Jun;150(1-2):14-20. doi: 10.1016/j.jviromet.2008.02.009. Epub 2008 Apr 2.

PMID:
18387679
5.

US Civilian Smallpox Preparedness and Response Program, 2003.

Strikas RA, Neff LJ, Rotz L, Cono J, Knutson D, Henderson J, Orenstein WA.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S157-67. doi: 10.1086/524751.

PMID:
18284355
6.

Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.

Borges MB, Kato SE, Damaso CR, Moussatché N, da Silva Freire M, Lambert Passos SR, do Nascimento JP.

Biologicals. 2008 Mar;36(2):105-10. Epub 2007 Sep 24.

PMID:
17892944
7.

Detailed kinetics of immune responses to a new cell culture-derived smallpox vaccine in vaccinia-naïve adults.

Kim SH, Choi SJ, Park WB, Kim HB, Kim NJ, Oh MD, Choe KW.

Vaccine. 2007 Aug 14;25(33):6287-91. Epub 2007 Jun 11.

PMID:
17597266
8.

Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection.

Kan VL, Manischewitz J, King LR, Golding H.

AIDS. 2007 Feb 19;21(4):521-4.

PMID:
17301573
9.
10.

Bioterrorism: management of major biological agents.

Bossi P, Garin D, Guihot A, Gay F, Crance JM, Debord T, Autran B, Bricaire F.

Cell Mol Life Sci. 2006 Oct;63(19-20):2196-212. Review.

PMID:
16964582
11.

Subunit recombinant vaccine protects against monkeypox.

Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G.

J Immunol. 2006 Aug 15;177(4):2552-64.

12.

Immunity and immunological memory following smallpox vaccination.

Amanna IJ, Slifka MK, Crotty S.

Immunol Rev. 2006 Jun;211:320-37. Review.

PMID:
16824139
13.

Clinical and immunological comparison of smallpox vaccine administered to the outer versus the inner upper arms of vaccinia-naive adults.

Waibel KH, Golding H, Manischewitz J, King LR, Tuchscherer M, Topolski RL, Walsh DS.

Clin Infect Dis. 2006 Feb 15;42(4):e16-20. Epub 2006 Jan 10.

PMID:
16421781
14.

Poxvirus entry and membrane fusion.

Moss B.

Virology. 2006 Jan 5;344(1):48-54. Review.

15.

Transmission of monkeypox among persons exposed to infected prairie dogs in Indiana in 2003.

Kile JC, Fleischauer AT, Beard B, Kuehnert MJ, Kanwal RS, Pontones P, Messersmith HJ, Teclaw R, Karem KL, Braden ZH, Damon I, Khan AS, Fischer M.

Arch Pediatr Adolesc Med. 2005 Nov;159(11):1022-5.

PMID:
16275790
16.

Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera.

Eyal O, Olshevsky U, Lustig S, Paran N, Halevy M, Schneider P, Zomber G, Fuchs P.

J Virol Methods. 2005 Dec;130(1-2):15-21. Epub 2005 Jul 15.

PMID:
16024096
17.

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.

Virology. 2005 Sep 1;339(2):164-75.

18.

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.

Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, Reimann KA, Franchini G.

Nat Med. 2005 Jul;11(7):740-7. Epub 2005 Jun 12.

PMID:
15951823
19.

Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.

Viner KM, Isaacs SN.

Microbes Infect. 2005 Apr;7(4):579-83. Epub 2005 Mar 22.

PMID:
15848274
20.

The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program.

Poland GA, Grabenstein JD, Neff JM.

Vaccine. 2005 Mar 18;23(17-18):2078-81. Review.

PMID:
15755574

Supplemental Content

Support Center